Individual or all lectures listed here are public and
can be attended by anyone interested in the field.
|
September 1
|
09.00h
10.30h
|
R. Kulier (Geneva)
|
Presentation of the course and discussion.
Visit of the computer room
|
|
15.00h
|
A. Campana (Geneva)
C. D’Arcangues (WHO)
F. Santschi (IAMANEH)
G. McDonald (UNFPA)
F Baumann (Geneva Yaounde Cooperation) |
Introduction |
|
16.00h
|
E. Diczfalusy (Rönninge)
|
« From contraception
to reproductive health and to the demographic revolution » |
| 17.30h |
Get together party
|
Maternité |
| September 4 |
09.00h |
B. Leigh (WHO) |
Reproductive health
in developing countries |
|
10.30h
|
|
Visit of the CMU
library |
| September 5 |
09.00h |
H. Lucas (Geneva) |
Gametogenesis |
| 10.00h |
F. Urner (Geneva) |
Fertilization |
| 11.00h |
E. Tribolet (Geneva) |
Oxytocin in
Reproductive Biology |
| 14.00h |
A. Campana (Geneva) |
Medline |
| September 6 |
09.00h |
J.M. Dubuis (Geneva) |
Puberty : Physiology |
| 10.00h |
J.M. Dubuis (Geneva) |
Puberty : Pathology |
| 11.00h |
P. Mock ( Geneva) |
Menstrual Cycle |
| September 7 |
09.00h |
R.C. Gaillard
(Lausanne) |
Hypothalamo-pituitary-gonadal axis |
| 10.00h |
F. Pralong (Lausanne) |
Leptin in
Reproduction |
| 11.00h |
M. Aubert (Geneva) |
Regulation of GnRH
secretion |
| September 8 |
09.00h |
P. Bischof (Geneva) |
Implantation |
| 10.00h |
P. Bischof (Geneva) |
Implantation |
| 11.00h |
P. Bischof (Geneva) |
Hormone Receptors |
| September 11 |
09.00h |
C. Delozier (Geneva) |
Introduction to the
module and to the genetics consultation |
| 09.15h |
A. Bottani (Geneva) |
Genetic counseling :
Principles and examples |
| 10.00h |
S. Dahoun (Geneva) |
Chromosomal pathology
: pre-and postnatal diagnosis and counseling |
| 11.00h |
M. Morris (Geneva) |
Principles of
molecular genetic diagnosis |
| 14.00h |
J. Cottingham (WHO) |
Gender issues in
reproductive health research |
| September 12 |
09.00h |
M. Neerman (Geneva) |
Genes implicated in
sex differentiation |
| 10.00h |
C. Delozier (Geneva) |
The genetic
consultation in Ob-Gyn : Reproductive pathologies , prenatal
diagnosis and hereditary cancers |
| 11.00h |
S. Antonarakis
(Geneva) |
The human genome
project and its implications for the practice of medicine in the
21st century |
| 14.00h |
C. Delozier (Geneva) |
Visit of the Division
of Medical Genetics |
| September 13 |
*09.00h |
J. Villar (WHO) |
Introduction to the
module
Type of epidemiological studies
|
|
*10.00h |
R. Kulier (Geneva) |
Case control studies |
|
*11.00h |
G. Carroli (WHO) |
Randomised controlled
studies |
|
14.00h |
|
Visit of the WHO
library |
| September 14 |
*09.00h |
M. Gulmezoglu (WHO) |
Cohort studies |
|
*10.00h |
M. Boulvain (Geneva) |
Protocol development |
| September 15 |
*09.00h |
G. Carroli (WHO) |
Critical appraisal |
|
*10.00h |
M. Gülmezoglu (WHO)
|
Systematic reviews |
|
*11.00h |
M. Gülmezoglu (WHO) |
Cochrane
Library/Reproductive Health Library |
| September 18 |
**09.00h |
G. Carroli (WHO) |
Screening in
reproductive health |
|
**10.00h |
G. Piaggio (WHO) |
Strategies for data
analysis: 1. Observational studies |
|
**11.00h |
G. Piaggio (WHO) |
Strategies for data
analysis: 2. Randomized controlled studies |
| September 19 |
**09.00h |
J. Villar (WHO) |
Expressing study
results |
|
**10.00h |
G. Carroli (WHO)/ R. Kulier (Geneva)
|
Workshop : critical
analysis of a paper |
| September 20 |
**09.00h |
I. Shah / S.
Jejeebhoy (WHO) |
Contraceptive
prevalence trends globally |
|
**10.00h |
E. Ezcurra (WHO) |
Oral contraceptives |
|
**11.00h |
E. Ezcurra (WHO) |
Risks and benefits
and metabolic effects of Ocs |
| September 21 |
**09.00h |
P. Rowe (WHO) |
Intrauterine devices
and barrier methods |
|
**10.00h |
H. Peterson (WHO) |
Medical eligibility
criteria for contraceptive methods |
|
**11.00h |
H. Peterson (WHO) |
Female sterilization
|
| September 22 |
**09.00h |
C. d’Arcangues (WHO) |
Long-acting hormonal
methods for women |
|
**10.00h |
C. d’Arcangues (WHO) |
Natural methods |
|
**11.00h |
M. Mbizvo (WHO) |
Male contraception
|
| September 25 |
**09.00h |
H. Von Hertzen (WHO) |
Emergency
contraception |
|
**10.00h |
H. Von Hertzen (WHO) |
Induced abortion |
|
**11.00h |
D. Griffin (WHO) |
Immunocontraception |
| September 26 |
**09.00h |
Y. Wang (WHO) |
Research needs and
research agenda for male reproductive health |
|
**10.00h |
H. Bathija (WHO) |
Fertility control in
adolescence and premenopause |
|
**11.00h |
P. Van Look (WHO) |
Reproductive health
research at WHO |
| September 27 |
09.00h |
A. Campana (Geneva) |
Definition,
prevalence and etiology of infertility |
| 10.00h |
A. Campana (Geneva) |
Evaluation of the
infertile couple |
| 11.00h |
A. Campana (Geneva) |
Spontaneous abortion
|
| 14.00h |
A. Campana (Geneva) |
Internet |
| September 28 |
09.00h |
D. Chardonnens
(Geneva) |
Medical treatment of
female infertility |
| 10.00h |
G. de Candolle
(Geneva) |
Surgical treatment of
female infertility |
| 11.00h |
H. Lucas (Geneva) |
Assisted reproduction
technologies |
| 15.00h |
G. Benagiano (Geneva) |
Reproductive health :
a new dimension |
| September 29 |
09.00h |
G. Girardet (Geneva) |
Menopause |
| 10.00h |
D. de Ziegler
(Geneva) |
Hormone replacement
therapy |
| 11.00h |
J.-Ph. Bonjour
(Geneva) |
Osteoporosis |
| October 2 |
09.00h |
R. Martin-Du-Pan
(Geneva) |
Diagnostic methods in
male infertility |
| 10.00h |
A. de Agostini
(Geneva) |
Semen analysis |
| 11.00h |
G. de Boccard
(Geneva) |
Treatment of male
infertility |
| October 3 |
09.00h |
S. Nazeer (Geneva) |
Screening programmes
in gynaecological cancer |
| 10.00h |
E. Megevand (Geneva) |
Basic principles of
colposcopy and dysplasia management |
| 11.00h |
M. Toetsch (Geneva) |
Cytopathology |
| 14.00 |
S. Nazeer (Geneva) |
Visit of the
Cytopathology Laboratory |
| October 4 |
09.00h |
S. Nazeer / D.
Herbert (Geneva) |
Trophoblastic
diseases |
| 10.00h |
R. Auckenthaler
(Geneva) |
Urinary tract
infection in pregnancy |
| 11.00h |
R. Auckenthaler
(Geneva) |
Diagnostic tests |
| 14.00h |
M. Usher-Patel (WHO) |
a) The history of the
Safe Motherhood Initiative
b) The global perspective of the causes of maternal and neonatal
mortality |
| October 5 |
09.00h |
O. Irion (Geneva) |
HIV in pregnancy |
| 10.00h |
S. Nazeer (Geneva) |
Sexually transmitted
diseases |
| 10.30h |
A. Major (Geneva) |
Ovarian Cancer |
| 11.15h |
G. Vlastos (Geneva) |
Breast Cancer and
reproductive health |
| 14.00h |
M. Usher-Patel (WHO) |
Case studies/Group
work |
| October 6 |
09.00h |
M. Boulvain (Geneva) |
Anaemia in pregnancy |
| 10.00h |
J.-C. Schellenberg
(Geneva) |
Post partum
haemorrhage |
| 11.00h |
O. Irion (Geneva)
|
Preeclampsia
|
| 14.00h |
J.-C. Schellenberg
(Geneva) |
Prematurity |
| October 9 |
09.00h |
R. Pfister (Geneva) |
Neonatal examination;
resuscitation in the delivery unit |
| 10.00h |
C. Stan (Geneva) |
Prevention of
neonatal infections |
| 11.00h |
P. Huppi (Geneva) |
Brain development in
the newborn infant |
| 14.00h |
M. Morales (Geneva) |
Visit of the delivery
room |
| October 10 |
***09.00h
to 12.00h |
M. Usher-Patel (WHO) |
a) Integrated
Management of Pregnancy and Childbirth (IMPAC)
b) Managing Complications of Pregnancy and Childbirth : A guide
for District Managers
c) Review of the Essential Care Practice Guide
d) Workshop |
| October 11 |
09.00h |
|
Oral Exams |
| 14.00h |
|
Oral Exams |
| October 12 |
09.00h |
|
Oral Exams |
| 14.00h |
|
Oral Exams |
| October 13 |
09.00h |
|
Written Exams |